Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING, China, Nov. 7, 2024 ...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today announced that the U.S. Food and Drug ...

In the vast world of health and wellness, traditional remedies are gaining increasing attention due to their natural formulations and time-tested benefits. One such emerging supplement is Nagano Tonic ...

Excessive daytime sleepiness or lack of interest caused by sleep problems may increase the risk of developing motoric cognitive risk syndrome (MCR), which could lead to dementia.

New research from reveals that the gut microbiome regulates the body’s diurnal (day-night) rhythms in stress hormones. Depletion of gut microbiota results in disruptions in the brain’s core circadian ...

Naitive ® Technologies Ltd., a population health company dedicated to developing innovative solutions in musculoskeletal care, today announced a strategic agreement with world-renowned ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

Children living in high tuberculosis (TB) burden areas are at a higher risk of developing TB by the age of 10.

AI-driven discovery of Halicin offers a breakthrough in combating antibiotic-resistant bacteria, addressing one of modern ...

Project Title Fragment and structure-based hit generation platform for new malaria targets Collaboration Partners 1.

Informing and empowering people impacted by CML, a once-fatal blood cancer now a manageable disease TORONTO , Nov.

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and ...